trans-4-Methylcyclohexanamine hydrochloride, 97.0%, 500g

4,4'-(5'-(4-(1H-Pyrazol-4-yl)phenyl)-[1,1':3',1''-terphenyl]-4,4''-diyl)bis(1H-pyrazole), 97%, 1g

Bilirubine, pa, 250 mg, emballage en verre

((E)-1-But-1-enyl)-pyrrolidine, 95.0%, 5g

9-(3-Bromophenyl)-9H-3,9'-bicarbazole, 98%, 250mg

Flacon à col large carré en verre marron, 500 ml, 54, forme courte, 10 Pièce(s)

Fmoc-D-Asp(OtBu)-OH, 98%, 5g

2,4,6-Trichlorobenzonitrile>98.0%(GC)5g

4-Methoxy-4'-methyldiphenylamine>98.0%(GC)(T)5g

Benzyl (3S)-3-(oxetan-3-yl)amino)pyrrolidine-1-carboxylate, 1g

Cyclohexanecarboxylic acid anhydride, 90.0%, 25g

3'-[8-(1,4-dioxa-8-azaspiro[4.5]decyl)methyl]-2-methyl benzophenone, 97.0%, 1g

2-(2,5-Difluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 250mg